Scheme 4.39. Enantioselective aziridinium and episulfonium ring‐opening.
Source: Based on [128].
Another novel application of chiral‐anion catalysis was demonstrated in 2018 by the Nicewicz group. In this report, a pyrillium/chiral phosphate salt was developed that was catalytically active for a photoredox catalyzed Diels‐Alder, providing bicyclic cyclohexene products in good yield and moderate enantioselectivity (Scheme 4.40) [130]. Impressively, the reaction could also be conducted intermolecularly, with a cyclic or acyclic diene. This represents a rare example in chiral ion‐pairing catalysis, where the reactivity of radical intermediates is leveraged in an asymmetric fashion.
Scheme 4.40. Asymmetric Diels Alder via photoredox/chiral anion dual catalysis.
Source: Based on [130].
4.3.5. Chiral‐Anion Phase Transfer
4.3.5.1. Halogenation
In 2011, the Toste group introduced a novel concept in the field of ion‐pairing catalysis, focused on a chiral‐anion phase transfer (CAPT) strategy (Scheme 4.41) [131]. The initial report focused on utilizing a catalytically generated SelectFluor/chiral phosphate ion‐pair for the asymmetric fluorocyclization of alkenes. In this system, a deprotonated chiral phosphoric acid catalyst undergoes salt metathesis with insoluble SelectFluor, which introduces a chiral environment around the electrophilic fluorine, allowing it to be transferred with high yields and enantioselectivities to a variety of alkenes. In this system, the phosphate anion serves a dual purpose of activating the substrate via hydrogen bonding and ion‐pairing with the cationic reagent.
In the decade following the initial report of CAPT catalysis, numbers of enantioselective fluorination reactions have been reported with the chiral phosphoric acid/SelectFluor system (Scheme 4.42). Enantioselective difunctionalization of alkenes constitutes a plurality of this field, and includes enantioselective fluorocyclizations of tryptamines [132], tryptophols [133], and enamides [134], as well as fluorinative semi‐pinacol rearrangement with sulfonamides [135] and alcohols [136]. In addition to difunctionalization reactions, enantioselective α‐fluorinations have also been demonstrated with this system, such as with enamides [137], phenols [138], and branched cyclohexanones [139]. The final class of transformations promoted by this system is enantioselective allylic fluorinations, with amide‐ and phenol‐directing groups [140]. From this, it was later shown that enantioselective fluorination could be accomplished with allylic [141] and homoallylic alcohols [142], utilizing a condensed boronic‐acid‐directing group [143].
Catalysts other than chiral phosphoric acids have also been demonstrated to be compatible with the CAPT strategy. The Hamashima group developed a bifunctional catalyst that mimics the dual functional nature of the chiral phosphate phase‐transfer catalysts (Scheme 4.43) [144]. This catalyst affected the endo‐fluorolactonization of 2‐styrenal benzoic acids, where the catalyst’s free alcohol group serves to hydrogen bond with the substrate, while the carboxylate ion‐pairs with the SelectFluor cation. A dimeric version of the catalyst featuring two carboxylates was later developed to synergize with the dicationic nature of SelectFluor. This catalyst was utilized for selective endo‐fluorocyclization with an amide nucleophile [145], as well as allylic fluorination [146].
Scheme 4.41. First example of chiral anion phase‐transfer catalysis.
Source: Based on [131].
Scheme 4.42. Overview of chiral anion phase‐transfer catalyzed fluorination reactions.
Scheme 4.43. Chiral anion phase‐transfer catalyzed fluorination with BINOL‐derived carboxylate catalysts.
Source: Based on [144].
In addition to fluorination with SelectFluor, CAPT catalysis was adapted to bromo‐ and iodocyclizations by utilizing DABCOnium‐based halogenating reagents (Scheme 4.44) [147]. This was first demonstrated by the Toste group with halocyclization of alkenes with tailored‐reagents based on the SelectFluor scaffold. This strategy was found to be applicable to bromocyclization of difluoroalkenes, providing access to tetrasubstituted CF2Br‐containing stereocenters [148]. These compounds were derivatized to a variety of pharmaceutically relevant difluoromethylene‐containing moieties, such as difluoromethyl, difluoroester, and difluorophosphonate. The DABCOnium‐based brominating reagents have been applied to the enantioselective bromocyclization of other classes of substrates, such as tryptamines [149], tryptophols [150], and indenes [151]. Similarly to asymmetric fluorination, the CAPT bromination and iodination strategies were applicable to reactions outside of halocyclizations, such as halogenative semi‐pinacol rearrangements [136] as well as atroposelective bromination [152].
4.3.5.2. Amination
Due to the generality of the CAPT strategy, other cationic electrophiles could be deemed asymmetric by amending them to a phase‐transfer setting. In 2014, the Toste group demonstrated that aryl diazonium salts were suitable electrophiles for CAPT catalysis, by developing an asymmetric diazenation of tryptamines (Scheme 4.45) [153]. In a 2015 follow‐up publication, the strategy was applied to carbonyl‐containing nucleophiles to generate quaternary diazenated stereocenters [154].
4.3.5.3. Miscellaneous Transformations
In 2013, the Toste group demonstrated the compatibility of oxopiperidinium salts in conjunction with CAPT catalysis for an enantioselective cross‐dehydrogenative coupling reaction (Scheme 4.46) [155].